Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
fatty liver disease
Marketing
Docs sing praises of Madrigal's Rezdiffra, predict rapid uptake
More than three-quarters of gastroenterologists surveyed expect to trial the brand within six months of its launch.
Nick Paul Taylor
Apr 8, 2024 7:45am
NASH market fattening up as wait for liver treatments drags on
Dec 4, 2023 10:49am
Meet Madrigal, which wants to be your liver's No. 1 fan
Nov 15, 2023 9:40am
NASH market holds 'enormous untapped potential,' analysts say
Aug 10, 2023 10:00am
UPDATED: Intercept restructures as NASH hopes dashed by FDA
Jun 22, 2023 6:20pm
FDA calls AdComm for Intercept's NASH drug application
Mar 10, 2023 11:18am